Home/Filings/4/0000875320-25-000085
4//SEC Filing

Biller Jonathan 4

Accession 0000875320-25-000085

CIK 0000875320other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:28 PM ET

Size

6.1 KB

Accession

0000875320-25-000085

Insider Transaction Report

Form 4
Period: 2025-02-14
Biller Jonathan
EVP and Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-14$463.46/sh1,504$697,04419,263 total
  • Sale

    Common Stock

    2025-02-18$455.06/sh1,657$754,03417,606 total
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001744749

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:28 PM ET
Size
6.1 KB